(Q57075224)

English

ALTITUDE Trial and Dual RAS Blockade: The Alluring but Soft Science of the Surrogate End Point

article published in 2013

In more languages

default for all languages

No label defined

No description defined

edit

Statements

0 references

0 references

ALTITUDE Trial and Dual RAS Blockade: The Alluring but Soft Science of the Surrogate End Point (English)

0 references

Sripal Bangalore

2

0 references

Franz H. Messerli

series ordinal

1

object named as

Franz H. Messerli

0 references

language of work or name

English

0 references

publication date

March 2013

0 references

published in

American Journal of Medicine

0 references

volume

126

0 references

issue

3

0 references

page(s)

e1-e3

0 references

cites work

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1016/S0140-6736(03)12229-5

Identifiers

DOI

10.1016/J.AMJMED.2012.07.006

0 references

PubMed publication ID

23332648

0 references

(Q57075224)

ALTITUDE Trial and Dual RAS Blockade: The Alluring but Soft Science of the Surrogate End Point

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)